Your browser is no longer supported. Please, upgrade your browser.
JAZZ Jazz Pharmaceuticals plc weekly Stock Chart
JAZZ [NASD]
Jazz Pharmaceuticals plc
Index- P/E11.66 EPS (ttm)11.08 Insider Own2.20% Shs Outstand56.64M Perf Week-1.67%
Market Cap7.32B Forward P/E7.55 EPS next Y17.11 Insider Trans-0.88% Shs Float55.12M Perf Month-3.47%
Income655.90M PEG0.73 EPS next Q3.58 Inst Own93.90% Short Float5.04% Perf Quarter-3.84%
Sales1.99B P/S3.68 EPS this Y34.60% Inst Trans-1.05% Short Ratio5.91 Perf Half Y-5.41%
Book/sh52.61 P/B2.46 EPS next Y14.20% ROA12.20% Target Price170.38 Perf Year-20.74%
Cash/sh15.58 P/C8.29 EPS next 5Y16.00% ROE22.80% 52W Range113.52 - 169.82 Perf YTD4.24%
Dividend- P/FCF9.63 EPS past 5Y15.80% ROI12.20% 52W High-23.91% Beta1.12
Dividend %- Quick Ratio3.50 Sales past 5Y16.70% Gross Margin94.30% 52W Low13.82% ATR3.35
Employees1360 Current Ratio3.70 Sales Q/Q6.70% Oper. Margin35.80% RSI (14)46.44 Volatility2.08% 2.57%
OptionableYes Debt/Eq0.54 EPS Q/Q203.50% Profit Margin33.00% Rel Volume1.58 Prev Close129.25
ShortableYes LT Debt/Eq0.53 EarningsAug 06 AMC Payout0.00% Avg Volume470.29K Price129.21
Recom1.90 SMA200.27% SMA50-3.25% SMA200-3.00% Volume740,892 Change-0.03%
Aug-21-19Downgrade Piper Jaffray Overweight → Neutral $205 → $142
Jun-11-19Initiated Barclays Overweight $164
Mar-20-19Initiated SunTrust Buy $163
Dec-14-18Initiated Wolfe Research Peer Perform
Nov-08-18Reiterated B. Riley FBR Buy $219 → $190
Aug-08-18Reiterated Stifel Buy $180 → $205
Jul-11-18Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-23-18Reiterated H.C. Wainwright Neutral $150 → $160
Mar-19-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-03-18Initiated Leerink Partners Outperform $180
Dec-05-17Reiterated Mizuho Neutral $144 → $150
Nov-10-17Resumed H.C. Wainwright Neutral $150
Nov-08-17Reiterated RBC Capital Mkts Outperform $210 → $195
Oct-19-17Initiated FBR & Co. Buy $206
Oct-05-17Initiated Morgan Stanley Equal-Weight $155
Sep-28-17Initiated Goldman Neutral $165
Aug-25-17Initiated H.C. Wainwright Neutral $144
May-31-17Reiterated Mizuho Neutral $150 → $144
May-15-17Initiated RBC Capital Mkts Outperform $210
Apr-06-17Downgrade Mizuho Buy → Neutral $162 → $150
Sep-20-19 04:43PM  Biotechs Fly Sideways In Quiet Week 5 News Items You May Have Missed Investor's Business Daily
09:23AM  Jazz Pharmaceuticals Has Good News on Narcolepsy Drug, Analyst Says Barrons.com
Sep-18-19 04:05PM  Jazz Pharmaceuticals Announces Webcast for World Sleep Congress Investor Update PR Newswire
Sep-07-19 10:36AM  Here's Why I Think Jazz Pharmaceuticals (NASDAQ:JAZZ) Is An Interesting Stock Simply Wall St.
Sep-06-19 09:40AM  JAZZ vs. CTLT: Which Stock Is the Better Value Option? Zacks
09:10AM  Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? Zacks
07:52AM  Jazz Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy? Zacks
07:27AM  The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication Benzinga
Sep-05-19 06:44PM  Edited Transcript of JAZZ earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
09:31AM  Jazz (JAZZ) Down 7.4% Since Last Earnings Report: Can It Rebound? Zacks
Aug-27-19 04:05PM  Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences PR Newswire
02:51PM  5 GARP Stocks To Buy Today InvestorPlace
Aug-20-19 07:04AM  Is Jazz Pharmaceuticals (NASDAQ:JAZZ) A Risky Investment? Simply Wall St.
Aug-14-19 09:40AM  Is Jazz Pharmaceuticals (JAZZ) a Profitable Value Stock? Zacks
Aug-13-19 12:59PM  Jazz buys Virginia biotech firm in deal valued at up to $312.5M American City Business Journals
11:12AM  Jazz (JAZZ) Acquires Cavion, Adds Movement Disorder Candidate Zacks
07:25AM  The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results Benzinga
Aug-12-19 04:01PM  Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc. PR Newswire
Aug-09-19 03:24AM  (PFNX) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 11:20AM  Jazz Pharma (JAZZ) Q2 Earnings and Sales Beat Estimates Zacks
06:30AM  Jazz Pharmaceuticals Sings a Sweet Tune in Q2 Motley Fool
05:24AM  Jazz Pharmaceuticals (JAZZ) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 07:15PM  Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue Estimates Zacks
04:05PM  Jazz Pharmaceuticals Announces Second Quarter 2019 Financial Results PR Newswire
04:01PM  Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program PR Newswire
Aug-02-19 09:06AM  What's in the Cards for Bausch Health (BHC) in Q2 Earnings? Zacks
08:44AM  Is a Beat in the Cards for Regeneron (REGN) Q2 Earnings? Zacks
Jul-31-19 09:27AM  Is There An Opportunity With Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) 34% Undervaluation? Simply Wall St.
Jul-30-19 10:38AM  Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy? Zacks
Jul-25-19 09:20AM  Jazz (Pharmaceuticals) Has Pizzazz With Quant Upgrade and Bullish Charts TheStreet.com
Jul-24-19 10:10AM  Will Jazz (JAZZ) Beat Estimates Again in Its Next Earnings Report? Zacks
Jul-23-19 04:05PM  Jazz Pharmaceuticals to Report 2019 Second Quarter Financial Results on August 6, 2019 PR Newswire
Jul-14-19 09:00AM  3 Incredibly Cheap Healthcare Stocks Motley Fool
Jul-10-19 11:57AM  Jazz Pharmaceuticals signs multimillion-dollar deal for experimental cancer therapy American City Business Journals
10:22AM  Jazz (JAZZ) Acquires Early-Stage Precision Oncology Asset Zacks
07:17AM  The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV Benzinga
02:00AM  Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma PR Newswire
Jul-05-19 09:54AM  Do You Know What Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) P/E Ratio Means? Simply Wall St.
Jul-03-19 08:00AM  ETF & Stock Winners of Longest US Economic Expansion Zacks
Jun-25-19 04:05PM  Jazz Pharmaceuticals Announces Webcast for Sunosi Investor Update PR Newswire
Jun-24-19 09:30AM  JAZZ or PCRX: Which Is the Better Value Stock Right Now? Zacks
Jun-21-19 11:23AM  Philadelphia location is fueling Jazz Pharmaceuticals' job growth American City Business Journals
Jun-20-19 02:49PM  Heres What Hedge Funds Think About Jazz Pharmaceuticals Public Limited Company (JAZZ) Insider Monkey
Jun-18-19 09:45AM  Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status Zacks
Jun-17-19 08:00AM  Jazz Pharmaceuticals Receives Schedule IV Designation from DEA for Sunosi (solriamfetol) PR Newswire
Jun-14-19 09:10AM  Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? Zacks
Jun-06-19 12:23PM  Should You Worry About Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) CEO Pay? Simply Wall St.
09:31AM  Why Is Jazz (JAZZ) Down 7.3% Since Last Earnings Report? Zacks
Jun-05-19 09:30AM  JAZZ or ZTS: Which Is the Better Value Stock Right Now? Zacks
Jun-03-19 08:00AM  Jazz Pharmaceuticals Appoints Dr. Robert Iannone as Executive Vice President, Research and Development PR Newswire
May-31-19 07:34AM  The Daily Biotech Pulse: Merrimack To Stay Independent, Chinese Cheer For Beigene, XBiotech Offering Benzinga
May-28-19 09:36AM  Zacks.com featured highlights include: Gilead, Jazz, Amdocs, Arch Capital and Legg Mason Zacks
May-27-19 08:45AM  Is Jazz (JAZZ) a Solid Growth Stock? 3 Reasons to Think " Yes " Zacks
May-24-19 09:16AM  5 Best PEG Stocks Suitable for GARP Investors Zacks
May-20-19 09:30AM  JAZZ vs. PCRX: Which Stock Should Value Investors Buy Now? Zacks
May-17-19 09:10AM  Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now? Zacks
May-16-19 04:30PM  Jazz Pharmaceuticals to Present New Data at Upcoming ASCO Annual Meeting and EHA Congress PR Newswire
May-13-19 09:07PM  Edited Transcript of JAZZ earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-10-19 09:55AM  3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates Zacks
08:45AM  3 Reasons Why Growth Investors Shouldn't Overlook Jazz (JAZZ) Zacks
May-09-19 08:00AM  Jazz Pharmaceuticals Data to Showcase Ongoing Sleep Medicine Research at SLEEP 2019 PR Newswire
07:46AM  These 3 revolutionary genomics companies are changing lives for patients and investors MarketWatch
May-08-19 08:01AM  Jazz Pharma (JAZZ) Q1 Earnings and Sales Beat Estimates Zacks +9.28%
06:00AM  Jazz Pharmaceuticals Hits All the Right Notes in Q1 Motley Fool
01:24AM  Jazz Pharmaceuticals (JAZZ) Q1 2019 Earnings Call Transcript Motley Fool
May-07-19 07:35PM  Jazz Pharmaceuticals (JAZZ) Beats Q1 Earnings and Revenue Estimates Zacks
06:29PM  Jazz: 1Q Earnings Snapshot Associated Press
04:05PM  Jazz Pharmaceuticals Announces First Quarter 2019 Financial Results PR Newswire
01:07PM  5 Stocks With Low Price-Earnings Ratios GuruFocus.com
May-06-19 04:05PM  Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences PR Newswire
01:40PM  What Should Investors Know About Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Earnings Outlook? Simply Wall St.
May-02-19 09:30AM  JAZZ vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
Apr-30-19 10:32AM  Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-29-19 09:15AM  Zoetis (ZTS) Hits Fresh High: Is There Still Room to Run? Zacks
Apr-23-19 04:05PM  Jazz Pharmaceuticals to Report 2019 First Quarter Financial Results on May 7, 2019 PR Newswire
Apr-18-19 08:05PM  Are Hedge Funds Right About Jazz Pharmaceuticals? Insider Monkey
Apr-16-19 09:30AM  JAZZ vs. ZTS: Which Stock Is the Better Value Option? Zacks
08:47AM  Should We Be Cautious About Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) ROE Of 16%? Simply Wall St.
08:45AM  3 Reasons Why Jazz (JAZZ) Is a Great Growth Stock Zacks
Apr-11-19 09:46AM  Concert Pharma Initiates Early-Stage Schizophrenia Study Zacks
Apr-04-19 06:20PM  Drugmakers Jazz, Alexion, Lundbeck to pay $123 million to resolve U.S. charity kickback probe Reuters
06:16PM  Drugmakers Jazz, Alexion, Lundbeck to pay $123 mln to resolve U.S. charity kickback probe Reuters
10:34AM  Jazz Pharma, Alexion and Lundbeck to pay $122.6 million to resolve kickback allegations MarketWatch
Apr-01-19 05:00AM  Stocks That Would Have Made You Rich Today GOBankingRates
Mar-28-19 09:30AM  Jazz (JAZZ) Down 0.4% Since Last Earnings Report: Can It Rebound? Zacks
Mar-27-19 04:30PM  Jazz's Xyrem Follow-On Drug Succeeds in Phase III Study Zacks
07:52AM  The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO Benzinga
Mar-26-19 04:13PM  Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness PR Newswire
03:33PM  What Should Investors Know About The Future Of Jazz Pharmaceuticals plc's (NASDAQ:JAZZ)? Simply Wall St.
Mar-25-19 09:19AM  Health Care Digest: Genentech's tumor-agnostic cancer drug, Novartis' East Bay option and more American City Business Journals
Mar-21-19 07:51AM  The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering Benzinga
Mar-20-19 09:05PM  FDA approves Jazz Pharmaceuticals sleep disorder drug American City Business Journals
08:02PM  Jazz Pharma's sleep disorder treatment gets FDA nod Reuters
07:10PM  Jazz Pharma's sleep disorder treatment gets FDA nod Reuters
06:53PM  Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea PR Newswire
11:14AM  Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision Zacks
08:00AM  Here are the biggest analyst calls of the day: Lyft, Monster, FedEx, Rockwell Automation & more CNBC
Mar-19-19 11:09AM  FDA decision on Jazz Pharmaceuticals narcolepsy drug expected Wednesday American City Business Journals
Mar-12-19 09:56AM  Is Jazz Pharmaceuticals (JAZZ) a Good Value Investor Pick? Zacks
07:00AM  The Zacks Analyst Blog Highlights: Jazz Pharmaceuticals, Lululemon Athletica, ABIOMED and DexCom Zacks
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in adult and pediatric patients with narcolepsy; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease, a potentially life-threatening complication of hematopoietic stem cell transplantation; and Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia. The company also develops Solriamfetol for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea, as well as in Phase II clinical trial for EDS associated with Parkinson's disease; Vyxeos for acute myeloid leukemia; and JZP-258 to treat EDS and cataplexy with narcolepsy and potential treatment of idiopathic hypersomnia and a chronic neurological disorder. In addition, it sells psychiatry and other products. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; and XL-protein GmbH. The company is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Treacy PaulSVP, Technical OperationsAug 12Sale137.404,371600,58916,418Aug 14 05:33 PM
ENRIGHT PATRICK GDirectorAug 09Sale135.6572698,48117,663Aug 12 05:50 PM
Winningham Rick EDirectorAug 09Sale135.6572698,4824,424Aug 12 05:48 PM
Sohn Catherine A.DirectorAug 09Sale135.6572698,4828,848Aug 12 05:38 PM
Schnee ElmarDirectorAug 09Sale135.65817110,8257,197Aug 12 05:36 PM
RIEDEL NORBERT GDirectorAug 09Sale135.6572698,4827,685Aug 12 05:32 PM
O'Keefe Kenneth WDirectorAug 09Sale135.6572698,4825,644Aug 12 05:29 PM
McSharry Heather AnnDirectorAug 09Sale135.65787106,7568,637Aug 12 05:26 PM
Gray PeterDirectorAug 09Sale135.65787106,7579,315Aug 12 05:23 PM
BERNS PAUL LDirectorAug 09Sale135.6572698,4817,966Aug 12 05:07 PM
Treacy PaulSVP, Technical OperationsMar 06Sale135.411,060143,53520,649Mar 07 07:18 PM
Young Matthew P.EVP & CFOMar 06Sale135.411,152155,99236,200Mar 07 07:13 PM
Treacy PaulSVP, Technical OperationsMar 01Sale139.50874121,92321,709Mar 04 07:41 PM
Hooper Suzanne SawochkaEVP & General CounselFeb 27Option Exercise46.836,666312,16946,404Feb 27 09:10 PM
Hooper Suzanne SawochkaEVP & General CounselFeb 27Sale140.006,666933,24039,738Feb 27 09:10 PM
Young Matthew P.EVP & CFOFeb 27Sale137.91884121,91227,967Feb 27 08:38 PM
Young Matthew P.EVP & CFOFeb 26Sale125.931,032129,96029,885Feb 27 08:38 PM
Hooper Suzanne SawochkaEVP & General CounselDec 14Option Exercise46.833,295154,30544,518Dec 14 06:04 PM
Hooper Suzanne SawochkaEVP & General CounselDec 14Sale140.213,334467,46041,184Dec 14 06:04 PM
COZADD BRUCE CChairman & CEODec 03Sale151.781,000151,780277,688Dec 06 04:35 PM
Young Matthew P.EVP & CFONov 23Sale150.00700105,00032,068Nov 27 04:54 PM
Mulligan SeamusDirectorNov 15Buy144.5650,0007,228,0011,100,868Nov 19 05:32 PM
MILLER MICHAEL PATRICKEVP, US CommercialNov 13Sale149.2720029,85424,972Nov 14 08:08 PM
COZADD BRUCE CChairman & CEONov 01Sale159.451,300207,290278,615Nov 05 06:48 PM
Young Matthew P.EVP & CFOOct 15Sale158.08700110,65832,768Oct 17 04:29 PM
MILLER MICHAEL PATRICKEVP, US CommercialOct 12Sale158.4620031,69225,172Oct 16 04:28 PM
COZADD BRUCE CChairman & CEOOct 01Sale167.991,300218,387279,915Oct 03 04:42 PM